RxDoctor Payments Data

Henry Youga

Family Medicine · Dublin, OHNPI 1144286857

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,428 of the $4,388 with a category attached, or 78.1%. 4 manufacturers reported payments, led by Novartis at 32.9% of the total.

$4,388in general payments, 2019–2025

Across 19 payments — averaging $230.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Boehringer Ingelheim International GmbH$1K
  • Modernatx, Inc.$1K
  • Eli Lilly$561
$644,511in research payments, 2019–2025

Across 177 payments — averaging $3641.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$172K
  • AstraZeneca$168K
  • Eli Lilly$161K
  • Novartis$58K
  • GSK$50K
  • Alnylam Pharmaceuticals Inc.$20K
  • plus $16K from 3 others

What the payments were for

  • Travel & lodging$3,42878%
  • Food & beverage$96122%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,388 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Other family medicine in Dublin

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →